Associated Papers
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.
Anglesio MS et al.
Molecular Cancer Research : Mcr, 2008
Select a paper to view details